Partial breast versus whole breast radiation for early breast cancer
Part of Cancer, Injuries & trauma, Skin clinical trials.
This study compares two types of radiation therapy for early-stage breast cancer after lumpectomy: radiation to just the part of the breast where the cancer was removed (partial breast) versus radiation to the whole breast. The goal is to see if partial breast radiation works just as well, with fewer side effects and a shorter treatment time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 45 or older.
- You have early-stage breast cancer (small tumor, no spread to lymph nodes or distant parts of the body).
- Your cancer is hormone receptor-positive (ER or PR positive) or HER2-positive (if HER2-positive, you've had or are getting HER2-targeted therapy).
- You had breast-conserving surgery (lumpectomy) with clear margins (no cancer cells at the edge of the removed tissue).
- You are not pregnant or breastfeeding, and you haven't had radiation to the same breast before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of partial breast radiation: one session versus several shorter sessions. It aims to see if a single treatment is as effective and more convenient for women with early-stage breast cancer.
This trial studies whether treating only part of the breast with radiation works as well as treating the whole breast in people with early breast cancer after lumpectomy. It may help reduce radiation exposure to healthy tissue, while still controlling the cancer.
This trial compares a shorter course of radiation focused on part of the breast versus a standard approach after lumpectomy. It aims to see if treating a smaller area can control the cancer while reducing treatment burden.
This trial compares giving radiation only to part of the breast versus not giving radiation at all after breast-conserving surgery. It’s meant for women with early, hormone-driven breast cancer to see if skipping radiation can be safe and reduce treatment burden.
This trial tests whether a shorter course of radiation therapy (called hypofractionated) after lumpectomy is safe and works well for early breast cancer. It aims to make treatment more convenient while keeping the same benefits.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.